SID 2026Abstract 0015
Using the hidradenitis suppurativa skin organ culture model to assess mechanisms of action and efficacy in disease amelioration of FDA approved drugs
Viola-Söhnlein J, Fehrholz M, Nicodeme E, Bechara F, Schneider-Burrus S, Julia V, Pappelbaum K, Edelkamp J, Bertolini M
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Hidradenitis suppurativa
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.046 · Not in PubMed: details from Crossref